Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2021-08-05 00:00:00 ET · period of report 2021-07-30 · accession 0001104659-21-100783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-05 | 2021-07-30 | MBIO | Litchman Manuel MD | Pres, CEO, Dir | P - Purchase | $2.91 | +86.2K | 960.2K | +10% | +$250.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-07-30 | P | A | 86,206 | $2.91 | 960,241 | D | — | — | (F1) Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the purchase transactions on July 30, 2021, was $2.89 to $2.94. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares purchased at each separate price. (F2) Includes restricted stock units, which vest over various time periods. |